Decreased expression of activation markers on CD4 T lymphocytes of HIV-infected long-term non-progressors [1]

AIDS

Volumn 17, Issue 1, 2003, Pages 133-134

  Carbone, Javier ^a   Gil, Juana ^a   Benito, Jose Miguel ^a   Fernandez Cruz, Eduardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; LETTER; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; LYMPHOCYTE ACTIVATION; PROSPECTIVE STUDIES;

EID: 0037415036     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200301030-00021     Document Type: Letter

References (10)

1. Alatrakchi N, Di Martino V, Thibault V, Autran B. Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus. AIDS 2002; 16:713-717.
2. Valdez H, Carlson NL, Post AB, Asaad R, Heeger PS, Lederman MM, et al. HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. AIDS 2002; 16:1113-1118.
3. Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM, et al. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182:1759-1767.
4. Carbone J, Gil J, Benito JM, Navarro J, Muñoz-F A, Bartolome J, et al. Increased levels of activated subsets of CD4+ T cells add to the prognostic value of low CD4+ T cell counts in a cohort of HIV-infected drug users. AIDS 2000; 14:2823-2829.
5. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, Giorgi JV. Lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:332-340.
6. Benito JM, Zabay JM, Gil J, Bermejo M, Escudero A, Sanchez E, et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14-128-135.
7. Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP, Greene WC. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J Infect Dis 1998; 178:669-679.
8. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type I infection. AIDS Res Hum Retroviruses 1996; 12:585-592.
9. Ho HN, Hultin LE, Mitsuyasu RT, Matud SL, Hausner MA, Bockstoce D, et al. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993; 150:3070-3079.
10. Giorgi J, Ho HN, Hirji K, Chou CH, Hultin LE, O'Rourke SO, et al. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 1994; 170:775-781.